国际麻醉学与复苏杂志   2023, Issue (10): 4-4
    
不同镇痛方案应用于胸腔镜下肺楔形切除患者术后镇痛效果的评价
戚钰, 刘松涛, 郑文婷, 王立伟, 周海, 吴从友, 周美艳, 王龙, 徐海军1()
1.徐州市中心医院
Evaluation of the analgesic effect of different analgesic protocols in patients undergoing pulmonary wedge resection
 全文:
摘要:

目的 研究不同镇痛方案对胸腔镜下肺楔形切除术后的镇痛效果。 方法 选取2021年10月至2023年6月徐州市中心医院收治的120例拟行胸腔镜下肺楔形切除术的患者,按随机数表法将患者分为4组。4组均实施全凭静脉麻醉,A组予以舒芬太尼静脉自控镇痛(PCIA),B组予以胸壁+肋间神经阻滞联合舒芬太尼PCIA,C组予以艾司氯胺酮PCIA,D组予以胸壁+肋间神经阻滞联合艾司氯胺酮PCIA。记录术后2h、6h、24h、48h和72h的视觉模拟评分(VAS);比较4组麻醉前和术后48h疼痛介质水平[包括血清神经肽Y(NPY)和P物质(SP)]以及不良反应发生率。 结果 4组一般资料对比差异均无统计学意义(P>0.05);VAS评分经重复测量方差分析差异均有统计学意义(P<0.05);术后6h、24h各组VAS评分均高于术后2h,术后72h各组VAS评分均低于术后2h,术后48h、72h各组VAS评分均低于术后6h、24h,术后72h各组VAS评分均低于术后48h,且各时刻组间比较,D组VAS评分均低于其余3组,B组VAS评分均低于A组、C组,C组VAS评分均低于A组,上述差异均有统计学意义(P<0.05);4组术后48h血清NPY和SP水平均高于麻醉前(P<0.05),且组间比较,4组麻醉前时刻疼痛介质水平均无统计学差异(P>0.05),术后48h D组NPY和SP均低于其余3组(P<0.05);B组均低于A组和C组(P<0.05),C组均低于A组(P<0.05);4组不良反应发生率差异无统计学意义(P>0.05)。 结论 胸壁+肋间神经阻滞联合艾司氯胺酮静脉自控镇痛,对胸腔镜下肺楔形切除术后镇痛效果更好,同时可以更有效地抑制疼痛介质水平。

关键词: 静脉自控镇痛;艾司氯胺酮;区域神经阻滞;肺叶切除术;疼痛介质
Abstract:

Objective To study the analgesic effects of different perioperative analgesic regimens in patients underwent thoracoscopic lobectomy. Methods 120 patients who underwent pulmonary wedge resection in Xuzhou Central Hospital from Oct 2021 to Jun 2023 were enrolled and divided into 4 groups by random digital table method. The four groups were given general anesthesia, group A was given intravenous controlled analgesia by sufentanil (PCIA) , and group B was given chest wall + intercostal nerve block combined with intravenous controlled analgesia by sufentanil (PCIA), and group C was given intravenous controlled analgesia by esketamine (PCIA), and group D was given chest wall + intercostal nerve block combined with intravenous controlled analgesia by esketamine (PCIA). The general data and visual analogue scores (VAS) after 2h, 6h, 24h, 48h and 72h of operation were compared among the four groups. Before analgesia and after 48h of operation, the levels of pain mediators [including serum neuropeptide Y (NPY) and substance P (SP) ] and the incidences of adverse reactions were compared among the four groups. Results There were no significant differences in the general data among the four groups (P 0.05). The differences in VAS scores were statistically significant differences by repeated measurement analysis of variance (P 0.05). The VAS scores in the four groups after 6h and 24h of operation were higher than those after 2h of operation, which after 72h of operation were lower than those after 24h of operation, and those after 48h and 72h of operation were lower than those after 6h and 24h of operation, and the scores after 72h of operation were lower than those after 48h operation. Compared among the four groups, the VAS scores in group D were lower than the other three groups, which in group B were lower than those in group A and C, which in group C were lower than those in group A, with statistically significant differences (P 0.05). The NPY, and SP levels in the four groups after 48h of operation were higher than those before analgesia, and there were no significant differences in the levels of pain mediators among the four groups before analgesia (P 0.05). The NPY, and SP levels in group D after 48h of operation were lower than those in the other three groups (P 0.05), which in group B were lower than those in group A and C (P 0.05), and the levels in group C were lower than those in the group A(P 0.05). There was no significant difference in the adverse reactions among the four groups (P 0.05). Conclusion chest wall + intercostal nerve block combined with intravenous controlled analgesia by esketamine has better analgesic effect on pulomonary wedge resection, more effective effects on inhibit the expression of pain mediators.

Key words: Patient-controlled intravenous analgesia; esketamine; nerve block analgesia; Pulmonary wedge resection; Pain medium